-
恒瑞创新药卡瑞利珠单抗联合甲磺酸阿帕替尼和TACE用于肝癌的上市许可申请获受理
- 来源: https://bydrug.pharmcube.com/news/detail/e52478ede0711ec643afefcaf5bacc7a
- 73
- 2026-01-30
-
6亿大品种迎来新入局者，曲唑酮片博弈进入下半场
- 来源: https://news.yaozh.com/archive/47035.html
- 80
- 2026-01-30
-
全国首款！高端CT领域再现新突破
- 来源: https://news.yaozh.com/archive/47033.html
- 83
- 2026-01-30
-
-
-
-
-
-
-
